Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondrial and Redox-Based Therapeutic Strategies in Huntington's Disease
Lígia Fão, A. Cristina Rego
Antioxidants and Redox Signaling (2020) Vol. 34, Iss. 8, pp. 650-673
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations
Matteo Fields, Annalisa Marcuzzi, Arianna Gonelli, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3739-3739
Open Access | Times Cited: 45
Endoplasmic reticulum stress and the unfolded protein response: emerging regulators in progression of traumatic brain injury
Yayi Yang, Dengfeng Lu, Menghan Wang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 25
Interaction of Oxidative Stress and Misfolded Proteins in the Mechanism of Neurodegeneration
Andrey Y. Abramov, Elena Potapova, Viktor Dremin, et al.
Life (2020) Vol. 10, Iss. 7, pp. 101-101
Open Access | Times Cited: 84
Reappraisal of metabolic dysfunction in neurodegeneration: Focus on mitochondrial function and calcium signaling
Pooja Jadiya, Joanne F. Garbincius, John W. Elrod
Acta Neuropathologica Communications (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 58
Sirtuins at the Crossroads between Mitochondrial Quality Control and Neurodegenerative Diseases: Structure, Regulation, Modifications, and Modulators
Hui Xu, Yiyang Liu, Lin-Seng Li, et al.
Aging and Disease (2023) Vol. 14, Iss. 3, pp. 794-794
Open Access | Times Cited: 26
Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington’s disease
Alaa Shafie, Amal Adnan Ashour, Saleha Anwar, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 6, pp. 571-595
Closed Access | Times Cited: 9
The Role of Sirtuin 1 in Ageing and Neurodegenerative Disease: A Molecular Perspective
Riya Thapa, Ehssan Moglad, Muhammad Afzal, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102545-102545
Closed Access | Times Cited: 9
Hormesis and Oxidative Distress: Pathophysiology of Reactive Oxygen Species and the Open Question of Antioxidant Modulation and Supplementation
Mariapaola Nitti, Barbara Marengo, Anna Lisa Furfaro, et al.
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1613-1613
Open Access | Times Cited: 31
Therapeutic Strategies in Huntington’s Disease: From Genetic Defect to Gene Therapy
Anamaria Jurcău, Maria Carolina Jurcău
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1895-1895
Open Access | Times Cited: 28
A comprehensive perspective of Huntington’s disease and mitochondrial dysfunction
Yinghong Dai, Haonan Wang, Aojie Lian, et al.
Mitochondrion (2023) Vol. 70, pp. 8-19
Open Access | Times Cited: 16
The Neuroprotective Flavonoids Sterubin and Fisetin Maintain Mitochondrial Health under Oxytotic/Ferroptotic Stress and Improve Bioenergetic Efficiency in HT22 Neuronal Cells
Marie Goujon, Zhibin Liang, David Soriano‐Castell, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 460-460
Open Access | Times Cited: 7
Impacts of oxidants and antioxidants on the emergence and progression of Alzheimer's disease
Hamieh Goshtasbi, Parvin Samadi Pakchin, Ali Movafeghi, et al.
Neurochemistry International (2021) Vol. 153, pp. 105268-105268
Closed Access | Times Cited: 34
Cannabinol inhibits oxytosis/ferroptosis by directly targeting mitochondria independently of cannabinoid receptors
Zhibin Liang, David Soriano‐Castell, Devin Kepchia, et al.
Free Radical Biology and Medicine (2022) Vol. 180, pp. 33-51
Open Access | Times Cited: 23
Short-term swimming induces the enhancement of mitochondrial-, survival-, and proliferation-related proteins in the hippocampus of healthy aged mice without affecting behavior
Ricardo Augusto Leoni De Sousa, Caíque Olegário Diniz e Magalhães, Poliany Pereira Cruz, et al.
Sport Sciences for Health (2025)
Closed Access
C60 Fullerene Reduces 3-Nitropropionic Acid-Induced Oxidative Stress Disorders and Mitochondrial Dysfunction in Rats by Modulation of p53, Bcl-2 and Nrf2 Targeted Proteins
Olga Gonchar, A. V. Maznychenko, O. M. Klyuchko, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5444-5444
Open Access | Times Cited: 32
Redefining Roles: A Paradigm Shift in Tryptophan–Kynurenine Metabolism for Innovative Clinical Applications
Masaru Tanaka, Ágnes Szabó, László Vécsei
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12767-12767
Open Access | Times Cited: 4
Oxidative Stress and Mitochondrial Impairment: Key Drivers in Neurodegenerative Disorders
Pei Wen, Zhixin Sun, Fengting Gou, et al.
Ageing Research Reviews (2025), pp. 102667-102667
Closed Access
Molecular Mechanisms Underlying Muscle Wasting in Huntington’s Disease
Manuela Bozzi, Francesca Sciandra
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8314-8314
Open Access | Times Cited: 28
Mitochondrial Medicine: A Promising Therapeutic Option Against Various Neurodegenerative Disorders
Mohannad A. Almikhlafi, Mohammed Matoog Karami, Ankit Jana, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 5, pp. 1165-1183
Open Access | Times Cited: 16
Emerging role and mechanism of HACE1 in the pathogenesis of neurodegenerative diseases: A promising target
Caixia Zang, Hui Liu, Jingwen Ning, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116204-116204
Open Access | Times Cited: 3
Mitochondrial dysfunction as a therapeutic strategy for neurodegenerative diseases: Current Insights and Future Directions
Yingying Gu, Xinru Zhao, Nan Zhang, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102577-102577
Closed Access | Times Cited: 3
Mitostasis in age-associated neurodegeneration
Mrutyunjaya Panda, Maria Markaki, Nektarios Tavernarakis
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024), pp. 167547-167547
Closed Access | Times Cited: 1
Esculetin Provides Neuroprotection against Mutant Huntingtin-Induced Toxicity in Huntington’s Disease Models
Letizia Pruccoli, Carlo Breda, Gabriella Teti, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 1044-1044
Open Access | Times Cited: 10
Nicotinamide Adenine Dinucleotide Phosphate Oxidases Are Everywhere in Brain Disease, but Not in Huntington’s Disease?
Luisana Villegas, Anne Nørremølle, Kristine Freude, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 6
Oleuropein enhances proteasomal activity and reduces mutant huntingtin-induced cytotoxicity
Zih-Ning Huang, Sin-Yi Lee, Jie-Mao Chen, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top